Schechter Investment Advisors’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Schechter Investment Advisors’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,000	Closed	-$373K	–	783
2023 Q1	$373K	Hold	37,000	–	–	0.03%	475
2022 Q4	$378K	Sell	37,000 -1,000	-3%	-$10.1K	0.03%	573
2022 Q3	$382K	Hold	38,000	–	–	0.04%	601
2022 Q2	$380K	Sell	38,000 -5,000	-12%	-$50.3K	0.04%	623
2022 Q1	$433K	Sell	43,000 -5,000	-10%	-$50.6K	0.04%	575
2021 Q4	$483K	Buy	+48,000	New	+$486K	0.04%	513

Schechter Investment Advisors's LVACU Position: Q2 2023 in Review

Schechter Investment Advisors sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2023, closing a stake of 37,000 shares — an estimated $373K sold.

Schechter Investment Advisors first reported a position in LVACU in Q4 2021 and held it in 6 quarters. The position peaked at $483K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACU as of Q2 2023.

Schechter Investment Advisors reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Schechter Investment Advisors sold 37,000 LAVA Medtech Acquisition Corp. Unit shares in Q2 2023, an estimated $373K.
Schechter Investment Advisors first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Schechter Investment Advisors's LAVA Medtech Acquisition Corp. Unit position peaked at $483K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2023.

Based on Schechter Investment Advisors's 13F filing for Q2 2023, filed 26 Jul 2023.